You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Discontinuation of efalizumab

Showing 1 - 25 of 1,358
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))

Not yet recruiting
  • Secondary Antibody Deficiency
  • Immunoglobulin replacement therapy (IGRT)
  • (no location specified)
Nov 4, 2022

Functional Remission in Discharged Schizophrenia After Long-term

Recruiting
  • Schizophrenia
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center, Shanghai Jiao Tong University Sch
    Dec 28, 2022

    Rheumatoid Arthritis, Autoimmune Diseases, Influenza Trial in Seongnam-si, Seoul (MTX-hold)

    Completed
    • Rheumatoid Arthritis
    • +3 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +2 more
    Dec 14, 2022

    Safety of Suppressive Therapy With DALBAVANCINE in Device

    Completed
    • Prosthesis-related Infections
    • Dalbavancin Injection
    • Tourcoing, France
      CH Tourcoing
    Oct 12, 2023

    Type 2 Diabetes Trial in Roma (flash glucose monitoring continuous, capillary blood test, flash glucose monitoring intermittent)

    Recruiting
    • Type 2 Diabetes
    • flash glucose monitoring continuous
    • +2 more
    • Roma, Italy
      Fondazione Policlinico Universitario Campus Bio-Medico
    Oct 18, 2023

    Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Discontinuation of maintenance treatment
    • Cork, Ireland
      Cork University Hospital
    May 10, 2023

    Early Versus Delayed Enteral Nutrition in Critically Ill

    Completed
    • Enteral Nutrition
    • COVID-19 Acute Respiratory Distress Syndrome
      • Ankara, Turkey
        Ankara City Hospital
      Nov 12, 2023

      Chronic Myeloid Leukemia Trial in Worldwide

      Recruiting
      • Chronic Myeloid Leukemia
        • Montréal, Quebec, Canada
        • +25 more
        Jul 25, 2022

        Body Weight, Body Fat, Overweight Trial (Vigiis 101 Lactobacillus Capsules, Placebo Capsules)

        Not yet recruiting
        • Body Weight
        • +2 more
        • Vigiis 101 Lactobacillus Capsules
        • Placebo Capsules
        • (no location specified)
        May 18, 2023

        Synovial Tissue and Blood Signature of Rheumatoid Arthritis

        Active, not recruiting
        • Rheumatoid Arthritis
        • Evaluation of subclinical inflammation
        • Brescia, Lombardia, Italy
        • +2 more
        Mar 2, 2023

        Polycystic Ovary Syndrome Trial (Metformin)

        Completed
        • Polycystic Ovary Syndrome
        • (no location specified)
        Aug 22, 2023

        Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)

        Not yet recruiting
        • Atopic Dermatitis
        • Dupilumab - Discontinuation
        • +2 more
        • (no location specified)
        Nov 2, 2023

        Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease Trial in France (Discontinuation (or not

        Recruiting
        • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
        • End Stage Renal Disease
        • Discontinuation (or not initiation) of Immunosuppressive Therapy
        • Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®
        • Amiens, France
        • +54 more
        Jan 6, 2023

        Psoriasis Trial in Spain

        Recruiting
        • Psoriasis
          • Badalona, Barcelona, Spain
          • +12 more
          Mar 15, 2022

          Medication Overuse Headache Trial in Ankara (Intravenous hydration, Intravenous prednisolone, Intravenous lidocaine)

          Active, not recruiting
          • Medication Overuse Headache
          • Intravenous hydration
          • +2 more
          • Ankara, Turkey
            Diskapi Yildirim Beyazıt Teaching and Research Hospital
          Nov 2, 2022

          Obesity, Childhood Trial in Konya (Recovery profile from general anesthesia)

          Completed
          • Obesity, Childhood
          • Recovery profile from general anesthesia
          • Konya, Turkey
            Selcuk University Medical Faculty Hospital
          Jun 29, 2022

          Hyperlipidemias Trial (ANKASCIN 568-P Red yeast rice capsules, Placebo Capsules)

          Not yet recruiting
          • Hyperlipidemias
          • ANKASCIN 568-P Red yeast rice capsules
          • Placebo Capsules
          • (no location specified)
          Feb 10, 2023

          High Blood Sugar, Metabolic Syndrome Trial (ANKASCIN 568-P Red yeast rice capsules, Placebo Capsules)

          Not yet recruiting
          • High Blood Sugar
          • Metabolic Syndrome
          • ANKASCIN 568-P Red yeast rice capsules
          • Placebo Capsules
          • (no location specified)
          Feb 10, 2023

          Atopic Dermatitis, Atopic Dermatitis Eczema Trial (Lactic acid bacteria NTU 101, Placebo)

          Not yet recruiting
          • Atopic Dermatitis
          • Atopic Dermatitis Eczema
          • Lactic acid bacteria NTU 101
          • Placebo
          • (no location specified)
          Jan 30, 2023

          Selected Subjects With Advanced Solid Tumors Trial in Guangzhou (SKB264)

          Not yet recruiting
          • Selected Subjects With Advanced Solid Tumors
          • Guangzhou, Guangdong, China
            Sun Yat-sen University Cancer Center
          Nov 18, 2022

          Understand Performance of Vibegron in Overactive Bladder (OAB)

          Recruiting
          • Overactive Bladder
          • Homewood, Alabama
          • +67 more
          Jun 9, 2022

          Preeclampsia, Perinatal Haemorrhage Trial in Guangzhou (aspirin discontinuation, aspirin continuation)

          Not yet recruiting
          • Preeclampsia
          • Perinatal Haemorrhage
          • aspirin discontinuation
          • aspirin continuation
          • Guangzhou, Guangdong, China
            FANG HE
          Oct 26, 2023

          Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)

          Recruiting
          • Kaposiform Hemangioendothelioma
          • Kasabach-Merritt Syndrome
          • Shanghai, Shanghai, China
            Children's Hospital of Fudan University
          Oct 21, 2022

          Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

          Recruiting
          • Sarcoma
          • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
          • Beijing, China
            Peking University People's Hospital
          Nov 6, 2023

          Trachoma Trial in Niamey (Azithromycin)

          Recruiting
          • Trachoma
          • Niamey, Niger
            Programme National de Santé Oculaire (PNSO)
          Aug 3, 2022